delayed injection site reaction tirzepatide Treatment: Evidence-Based Management Guide Managing GLP-1 Injection Site Reactions:
Description
In this exploratory analysis, treatment with tirzepatide in people with T2D resulted in a significant reduction of z-VAT and z-LF, while z-aSAT was increased from an initially negative value, suggesting a possible treatment-related shift towards a more balanced fat distribution pattern with prominent VAT and LF loss, the researchers concluded
A shift of a few beats within that range is usually not a cause for concern on its own
Watch for automatic subscription and billing issues
In GLP-1s, we see figures in that range or worse
Yes, protein-based alternatives are often highly recommended for those on a weight loss program
